107 related articles for article (PubMed ID: 22399626)
1. Soluble human leukocyte antigen-G expression in patients with ductal and lobular breast malignancy.
Provatopoulou X; Kalogera E; Sagkriotis A; Zagouri F; Nonni A; Zografos GC; Gounaris A
Anticancer Res; 2012 Mar; 32(3):1021-6. PubMed ID: 22399626
[TBL] [Abstract][Full Text] [Related]
2. HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro.
He X; Dong DD; Yie SM; Yang H; Cao M; Ye SR; Li K; Liu J; Chen J
Ann Surg Oncol; 2010 May; 17(5):1459-69. PubMed ID: 20052552
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer.
Chen HX; Lin A; Shen CJ; Zhen R; Chen BG; Zhang X; Cao FL; Zhang JG; Yan WH
Hum Immunol; 2010 Sep; 71(9):892-8. PubMed ID: 20547193
[TBL] [Abstract][Full Text] [Related]
4. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer.
Cao M; Yie SM; Liu J; Ye SR; Xia D; Gao E
Tissue Antigens; 2011 Aug; 78(2):120-8. PubMed ID: 21726203
[TBL] [Abstract][Full Text] [Related]
5. Plasma soluble human leukocyte antigen-G expression is a potential clinical biomarker in patients with hepatitis B virus infection.
Shi WW; Lin A; Xu DP; Bao WG; Zhang JG; Chen SY; Li J; Yan WH
Hum Immunol; 2011 Nov; 72(11):1068-73. PubMed ID: 21762747
[TBL] [Abstract][Full Text] [Related]
6. Characterization of HLA-G expression in renal cell carcinoma.
Li BL; Lin A; Zhang XJ; Zhang X; Zhang JG; Wang Q; Zhou WJ; Chen HX; Wang TJ; Yan WH
Tissue Antigens; 2009 Sep; 74(3):213-21. PubMed ID: 19531101
[TBL] [Abstract][Full Text] [Related]
7. HLA-G is a potential tumor marker in malignant ascites.
Singer G; Rebmann V; Chen YC; Liu HT; Ali SZ; Reinsberg J; McMaster MT; Pfeiffer K; Chan DW; Wardelmann E; Grosse-Wilde H; Cheng CC; Kurman RJ; Shih IeM
Clin Cancer Res; 2003 Oct; 9(12):4460-4. PubMed ID: 14555519
[TBL] [Abstract][Full Text] [Related]
8. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.
Lefebvre S; Antoine M; Uzan S; McMaster M; Dausset J; Carosella ED; Paul P
J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488
[TBL] [Abstract][Full Text] [Related]
9. Analysis of HLA-G gene polymorphism and protein expression in invasive breast ductal carcinoma.
Ramos CS; Gonçalves AS; Marinho LC; Gomes Avelino MA; Saddi VA; Lopes AC; Simões RT; Wastowski IJ
Hum Immunol; 2014 Jul; 75(7):667-72. PubMed ID: 24759678
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients.
Schütt P; Schütt B; Switala M; Bauer S; Stamatis G; Opalka B; Eberhardt W; Schuler M; Horn PA; Rebmann V
Hum Immunol; 2010 May; 71(5):489-95. PubMed ID: 20156510
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma].
Huober J; Sprenger H; Costa SD; Zentgraf H; Schmid H; Kaufmann M; Bastert G
Zentralbl Gynakol; 1996; 118(10):560-4. PubMed ID: 8999710
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma.
Lin A; Zhang X; Zhou WJ; Ruan YY; Xu DP; Wang Q; Yan WH
Int J Cancer; 2011 Sep; 129(6):1382-90. PubMed ID: 21128238
[TBL] [Abstract][Full Text] [Related]
13. B7-h4 is highly expressed in ductal and lobular breast cancer.
Tringler B; Zhuo S; Pilkington G; Torkko KC; Singh M; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
Clin Cancer Res; 2005 Mar; 11(5):1842-8. PubMed ID: 15756008
[TBL] [Abstract][Full Text] [Related]
14. A novel tumor suppressor gene RhoBTB2 (DBC2): frequent loss of expression in sporadic breast cancer.
Mao H; Qu X; Yang Y; Zuo W; Bi Y; Zhou C; Yin H; Deng B; Sun J; Zhang L
Mol Carcinog; 2010 Mar; 49(3):283-9. PubMed ID: 19937980
[TBL] [Abstract][Full Text] [Related]
15. Expression of transcription factor CREB1 in human breast cancer and its correlation with prognosis.
Chhabra A; Fernando H; Watkins G; Mansel RE; Jiang WG
Oncol Rep; 2007 Oct; 18(4):953-8. PubMed ID: 17786359
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the plasma soluble human leukocyte antigen-G and interleukin-10 levels in childhood atopic asthma.
Zheng XQ; Li CC; Xu DP; Lin A; Bao WG; Yang GS; Yan WH
Hum Immunol; 2010 Oct; 71(10):982-7. PubMed ID: 20600443
[TBL] [Abstract][Full Text] [Related]
17. HLA-G and its relation to proliferation index in detection and monitoring breast cancer patients.
Sayed D; Badr G; Maximous D; Mikhail NN; Abu-Tarboush F; Alhazza IM
Tissue Antigens; 2010 Jan; 75(1):40-7. PubMed ID: 20196818
[TBL] [Abstract][Full Text] [Related]
18. Soluble human leukocyte antigen-g and its insertion/deletion polymorphism in papillary thyroid carcinoma: novel potential biomarkers of disease?
Dardano A; Rizzo R; Polini A; Stignani M; Tognini S; Pasqualetti G; Ursino S; Colato C; Ferdeghini M; Baricordi OR; Monzani F
J Clin Endocrinol Metab; 2012 Nov; 97(11):4080-6. PubMed ID: 22930786
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N
Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor genetic variation, breast cancer risk, and waiting time to onset of disease.
Araújo AP; Ribeiro R; Pinto D; Pereira D; Sousa B; Mauricio J; Lopes C; Medeiros R
DNA Cell Biol; 2009 May; 28(5):265-9. PubMed ID: 19388850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
